person · Reporting owner
Lewis Sara Grootwassink
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FREEPORT-MCMORAN INCFCX · Entity 2905 | Director | June 01, 2026 | June 02, 2026 |
| HEALTHPEAK PROPERTIES, INC.DOC · Entity 3364 | Director | May 06, 2026 | May 08, 2026 |
| PS BUSINESS PARKS, INC./MDPSB · Entity 125076 | Director | June 15, 2018 | June 18, 2018 |
| WEYERHAEUSER COWY · Entity 3314 | Director | May 15, 2026 | May 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FREEPORT-MCMORAN INC
Report date June 01, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,000 |
Reported balance
After 2026-06-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 2,800 · Balance 34,000 F1: Represents a grant of Common Stock Restricted Stock Units ("RSUs"). F2: Amount beneficially owned following the reported transaction includes 7,300 RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of Common Stock Restricted Stock Units ("RSUs").
F2: Amount beneficially owned following the reported transaction includes 7,300 RSUs.
HEALTHPEAK PROPERTIES, INC.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 56,488 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 9,744 · Balance 56,488 F1: Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders. |
| Common StockSEC Table I · non-derivative | IndirectTrust | 22,000 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 22,000 |
| Common StockSEC Table I · non-derivative | IndirectIRA | 9,000 |
Reported balance
Holding disclosure · report date 2026-05-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 9,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.
PS BUSINESS PARKS, INC./MD
Report date June 15, 2018 · Filed June 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,000 |
Ending reported balance
After 2018-06-15 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2018-06-15 · Exercise / conversion · Acquired 1,068 · Balance 4,068 F1: On December 15, 2014, PSB declared a special dividend, payable on December 30, 2014. As a result, pursuant to anti-dilution provisions of PSB's 2012 Equity and Performance-Based Compensation Plan, an option for 2,000 shares of common stock held by the reporting person on December 30, 2014 became exercisable for an additional 68 shares of common stock. Row 2 · 2018-06-15 · Exercise / conversion · Acquired 2,000 · Balance 6,068 Row 3 · 2018-06-15 · Exercise / conversion · Acquired 1,600 · Balance 7,668 Row 4 · 2018-06-15 · Exercise / conversion · Acquired 1,200 · Balance 8,868 Row 5 · 2018-06-15 · Exercise / conversion · Acquired 800 · Balance 9,668 Row 6 · 2018-06-15 · Exercise / conversion · Acquired 400 · Balance 10,068 Row 7 · 2018-06-15 · Sale · Disposed 7,068 · Balance 3,000 F2: Represents weighted average price. These shares were sold at prices ranging from $124.00 and $124.83. Full information regarding the number of shares purchased at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.00 · Expires 2022-04-30 | Direct | 0 |
Reported balance
After 2018-06-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-06-15 · Exercise / conversion · Disposed 1,068 · Balance 0 F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. F4: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.10 · Expires 2023-05-06 | Direct | 0 |
Reported balance
After 2018-06-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-06-15 · Exercise / conversion · Disposed 2,000 · Balance 0 F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $82.84 · Expires 2024-04-28 | Direct | 400 |
Reported balance
After 2018-06-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-06-15 · Exercise / conversion · Disposed 1,600 · Balance 400 F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $80.13 · Expires 2025-04-28 | Direct | 800 |
Reported balance
After 2018-06-15 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-06-15 · Exercise / conversion · Disposed 1,200 · Balance 800 F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $96.89 · Expires 2026-04-26 | Direct | 1,200 |
Reported balance
After 2018-06-15 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-06-15 · Exercise / conversion · Disposed 800 · Balance 1,200 F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $121.57 · Expires 2027-04-25 | Direct | 1,600 |
Reported balance
After 2018-06-15 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-06-15 · Exercise / conversion · Disposed 400 · Balance 1,600 F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 15, 2014, PSB declared a special dividend, payable on December 30, 2014. As a result, pursuant to anti-dilution provisions of PSB's 2012 Equity and Performance-Based Compensation Plan, an option for 2,000 shares of common stock held by the reporting person on December 30, 2014 became exercisable for an additional 68 shares of common stock.
F2: Represents weighted average price. These shares were sold at prices ranging from $124.00 and $124.83. Full information regarding the number of shares purchased at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer.
F3: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant.
F4: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014.
WEYERHAEUSER CO
Report date May 15, 2026 · Filed May 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share EquivalentsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 80,213.77 |
Reported balance
After 2026-05-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-15 · Grant · Acquired 7,832 · Balance 80,213.77 F1: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2: Reported holdings include stock equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director.
F2: Reported holdings include stock equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 2, 2026 21:34 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | GrantCommon Stock | 2,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-007082 · marketforms-73338.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,000 F1 · kind: Represents a grant of Common Stock Restricted Stock Units ("RSUs"). F2 · balance_after: Amount beneficially owned following the reported transaction includes 7,300 RSUs. Read SEC document |
| May 15, 2026 Filed May 19, 2026 21:20 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equivalents · Derivative | 7,832 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001165970-26-000005 · ownership.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,213.77 Underlying: Common · 7,832 shares Expires not disclosed F1 · shares: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The stock equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,832 restricted stock units into an equal number of stock equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $22.98, the average of the high ($23.40) and low ($22.56) price of the Issuer's common stock on the date of the grant. Additional stock equivalents accrue as and when dividends are paid on the Issuer's common stock. Stock equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include stock equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 06, 2026 Filed May 8, 2026 00:08 UTC | HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 | GrantCommon Stock | 9,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001165970-26-000002 · wk-form4_1778198905.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,488 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:23 UTC | WEYERHAEUSER CO WY · Entity 3314 | PurchaseCommon | 4,500 | $23.61 | $106,226.10 |
DisclosureSEC source: 0001193125-25-325117 · ownership.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,978 Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 21:21 UTC | WEYERHAEUSER CO WY · Entity 3314 | PurchaseCommon | 4,000 | $25.29 | $101,140.00 |
DisclosureSEC source: 0000950170-25-108170 · ownership.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,478 F1 · balance_after: Excludes 4,096 shares previously owned directly and currenlty owned indirectly by trust. Read SEC document |
| June 01, 2025 Filed Jun 3, 2025 21:27 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | GrantCommon Stock | 4,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-008783 · marketforms-69751.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,200 F1 · kind: Represents a grant of Common Stock Restricted Stock Units ("RSUs"). F2 · balance_after: Amount beneficially owned following the reported transaction includes 9,400 RSUs. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:31 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equivalents · Derivative | 6,849 | $26.28 Strike: $0.00 | $179,991.72 |
DisclosureSEC source: 0000950170-25-070553 · ownership.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,947.103 Underlying: Common · 6,849 shares Expires not disclosed F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,849 restricted stock units into an equal number of share equivalents. The restricted stock units (rounded down to the nearest whole unit) represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fee by $26.28, the average of the high ($26.50) and low ($26.06) price of the issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include share equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 28, 2025 Filed Apr 28, 2025 21:52 UTC | HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 | PurchaseCommon Stock | 6,000 | $17.66 | $105,938.40 |
DisclosureSEC source: 0001628280-25-020387 · wk-form4_1745877140.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · IRA Disclosed balance after: 9,000 Read SEC document |
| April 25, 2025 Filed Apr 29, 2025 21:06 UTC | HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 | GrantCommon Stock | 10,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-020758 · wk-form4_1745960762.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,744 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 25, 2025 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| June 01, 2024 Filed Jun 4, 2024 21:38 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | GrantCommon Stock | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-010577 · marketforms-66153.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,300 F1 · kind: Represents a grant of Common Stock Restricted Stock Units ("RSUs"). F2 · balance_after: Amount beneficially owned following the reported transaction includes 8,000 RSUs. Read SEC document |
| May 10, 2024 Filed May 13, 2024 23:01 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equivalents · Derivative | 5,790 | $31.09 Strike: $0.00 | $179,982.15 |
DisclosureSEC source: 0000950170-24-058959 · ownership.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,467.344 Underlying: Common · 5,790 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,790 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $180,000, with the number of units determined by dividing the dollar amount of the fees by $31.085, the average of the high ($31.27) and low ($30.90) price of the Issuer's common stock on the date of the grant. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include share equivalents acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 26, 2024 Filed Apr 30, 2024 21:32 UTC | HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 | GrantCommon Stock | 9,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-019400 · wk-form4_1714512731.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,087 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 26, 2024 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| March 04, 2024 Filed Mar 4, 2024 22:46 UTC | HEALTHPEAK PROPERTIES, INC. DOC · Entity 3364 | PurchaseCommon Stock | 18,000 | $16.71 | $300,780.00 |
DisclosureSEC source: 0001628280-24-008624 · wk-form4_1709592351.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Trust Disclosed balance after: 22,000 Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 21:39 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033949 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,800 F1 · security: Amount beneficially owned following the reported transaction includes 9,500 common stock restricted stock units ("RSUs"). F2 · kind: Represents a grant of RSUs. Read SEC document |
| May 12, 2023 Filed May 15, 2023 21:41 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equivalents · Derivative | 5,706 | $29.79 Strike: $0.00 | $169,981.74 |
DisclosureSEC source: 0001209191-23-029580 · doc4.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,115.923 Underlying: Common · 5,706 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 5,706 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $170,000, with the number of units determined by dividing the dollar amount of the fees by $29.79, the average of the high ($29.99) and low ($29.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 12, 2023 Filed May 15, 2023 21:51 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | PurchaseCommon Stock | 4,000 | $34.90 | $139,596.80 |
DisclosureSEC source: 0001209191-23-029590 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,800 F1 · security: Amount beneficially owned following the reported transaction includes 4,500 common stock restricted stock units. Read SEC document |
| April 28, 2023 Filed May 1, 2023 22:46 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | GrantCommon Stock | 8,193 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-014706 · wf-form4_168298118792456.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,512 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 28, 2023 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:59 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | PurchaseCommon Stock | 4,000 | $21.43 | $85,728.80 |
DisclosureSEC source: 0001628280-23-008339 · wf-form4_167900037390359.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 4,000 Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 21:29 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | PurchaseCommon Stock | 3,000 | $28.79 | $86,355.00 |
DisclosureSEC source: 0001209191-22-044446 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 F1 · security: Amount beneficially owned following the reported transaction includes 4,500 common stock restricted stock units. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 21:29 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-033647 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,800 F1 · security: Amount beneficially owned following the reported transaction includes 8,300 common stock restricted stock units ("RSUs"). F2 · kind: Represents a grant of RSUs. Read SEC document |
| May 16, 2022 Filed May 17, 2022 19:48 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equivalents · Derivative | 4,191 | $38.18 Strike: $0.00 | $159,991.43 |
DisclosureSEC source: 0001209191-22-029562 · doc4.xml · derivative · entry 4 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,113.052 Underlying: Common · 4,191 shares Expires not disclosed F4 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F4 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F4 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F4 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F4 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 4,191 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $160,000, with the number of units determined by dividing the dollar amount of the fees by $38.175, the average of the high ($38.76) and low ($37.59) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 14, 2022 Filed May 17, 2022 19:48 UTC | WEYERHAEUSER CO WY · Entity 3314 | Tax withholdingCommon | 80 | $38.71 | $3,096.80 |
DisclosureSEC source: 0001209191-22-029562 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,574 F1 · shares: These shares (rounded down to the nearest whole share) are being withheld to cover taxes for a restricted stock unit vesting. F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. F3 · balance_after: The Reporting Person received a cash payment in lieu of fractional shares. Read SEC document |
| April 28, 2022 Filed May 2, 2022 23:04 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | GrantCommon Stock | 5,258 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-22-011836 · wf-form4_165153265171092.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,319 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 28, 2022 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 21:49 UTC | FREEPORT-MCMORAN INC FCX · Entity 2905 | GrantCommon Stock | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-21-000878 · form.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 F1 · security: Amount beneficially owned following the reported transaction includes 3,800 common stock restricted stock units ("RSUs"). F2 · kind: Represents a grant of RSUs. Read SEC document |
| May 14, 2021 Filed May 18, 2021 23:53 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantCommon | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033789 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,378 F1 · shares: These shares were granted pursuant to a restricted stock unit award that vests 100% one year after the grant date. These shares (rounded down to the nearest whole share) represent the equity portion of the annual retainer fee in the amount of $150,000.00, with the number of restricted stock units determined by dividing the dollar amount of the fee by $38.455, the average of the high ($38.75) and low ($38.16) price of the issuer's common stock on the date of the grant. Read SEC document |
| April 29, 2021 Filed May 3, 2021 22:33 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | GrantCommon Stock | 4,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-21-008684 · wf-form4_162008118429570.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,061 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 29, 2021 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| May 15, 2020 Filed May 19, 2020 01:03 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equivalents · Derivative | 7,186 | $17.26 Strike: $0.00 | $123,994.43 |
DisclosureSEC source: 0001209191-20-030303 · doc4.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,719.283 Underlying: Common · 7,186 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 7,186 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $124,000, with the number of units determined by dividing the dollar amount of the fees by $17.255, the average of the high ($17.69) and low ($16.82) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 30, 2020 Filed May 4, 2020 22:08 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | GrantCommon Stock | 6,121 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-006298 · wf-form4_158863011059425.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,337 F1 · shares: Restricted stock units vest in full on the earlier of the first anniversary of the April 30, 2020 grant date or the Company's next annual meeting of stockholders. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:41 UTC | WEYERHAEUSER CO WY · Entity 3314 | PurchaseCommon | 5,000 | $17.96 | $89,799.50 |
DisclosureSEC source: 0001209191-20-020137 · doc4.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,478 Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:59 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | PurchaseCommon Stock | 3,000 | $32.13 | $96,377.40 |
DisclosureSEC source: 0001628280-20-002806 · wf-form4_158327637827691.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Plan Disclosed balance after: 3,000 F1 · price: The price reported in Column 4 is a weighted average sales price. These shares were purchased in multiple transactions at sale prices ranging from $32.1256 to $32.13. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein. Read SEC document |
| December 16, 2019 Filed Feb 6, 2020 01:11 UTC | WEYERHAEUSER CO WY · Entity 3314 | OtherCommon | 45 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007044 · doc5.xml · nonDerivative · entry 2 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By IRA Disclosed balance after: 45 F1 · shares: Represents shares acquired as part of an inheritance. Read SEC document |
| December 16, 2019 Filed Feb 6, 2020 01:11 UTC | WEYERHAEUSER CO WY · Entity 3314 | OtherCommon | 72 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007044 · doc5.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,478 F1 · shares: Represents shares acquired as part of an inheritance. Read SEC document |
| November 07, 2019 Filed Nov 12, 2019 23:01 UTC | HEALTHPEAK PROPERTIES, INC. PEAK · Entity 3364 | GrantCommon Stock | 2,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-014010 · wf-form4_157359969586711.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,216 F1 · shares: Represents a prorated initial grant of restricted stock units, which vests in full on April 23, 2020, the anticipated date of the issuer's next annual meeting of stockholders. Read SEC document |
| May 17, 2019 Filed May 21, 2019 00:17 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equilvalents · Derivative | 6,101 | $24.59 Strike: $0.00 | $149,993.09 |
DisclosureSEC source: 0001225208-19-008258 · doc4.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,723.683 Underlying: Common · 6,101 shares Expires not disclosed F1 · derivative.exercise_price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · shares: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · price: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The share equivalents reported herein were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer receipt of 6,101 restricted stock units into an equal number of share equivalents. The restricted stock units represent the equity portion of the annual retainer fee in the amount of $150,000, with the number of units determined by dividing the dollar amount of the fees by $24.585, the average of the high ($24.87) and low ($24.30) price of the Issuer's common stock on the fee payment date. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 400 | $0.00 Strike: $121.57 | $0.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 13 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 400 shares Expires 2027-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 800 | $0.00 Strike: $96.89 | $0.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 12 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200 Underlying: Common Stock · 800 shares Expires 2026-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 1,200 | $0.00 Strike: $80.13 | $0.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 11 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock · 1,200 shares Expires 2025-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 1,600 | $0.00 Strike: $82.84 | $0.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 10 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400 Underlying: Common Stock · 1,600 shares Expires 2024-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $79.10 | $0.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 9 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2023-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 1,068 | $0.00 Strike: $66.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · derivative · entry 8 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,068 shares Expires 2022-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. F4 · derivative.exercise_price: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014. F4 · shares: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | SaleCommon Stock | 7,068 | $124.45 | $879,587.16 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 7 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 F2 · price: Represents weighted average price. These shares were sold at prices ranging from $124.00 and $124.83. Full information regarding the number of shares purchased at each separate price will be provided by the reporting person upon request to the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionCommon Stock | 400 | $121.57 | $48,628.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 6 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionCommon Stock | 800 | $96.89 | $77,512.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 5 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionCommon Stock | 1,200 | $80.13 | $96,156.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 4 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionCommon Stock | 1,600 | $82.84 | $132,544.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 3 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionCommon Stock | 2,000 | $79.10 | $158,200.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 2 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 16:52 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionCommon Stock | 1,068 | $66.00 | $70,488.00 |
DisclosureSEC source: 0001140361-18-028993 · doc1.xml · nonDerivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On December 15, 2014, PSB declared a special dividend, payable on December 30, 2014. As a result, pursuant to anti-dilution provisions of PSB's 2012 Equity and Performance-Based Compensation Plan, an option for 2,000 shares of common stock held by the reporting person on December 30, 2014 became exercisable for an additional 68 shares of common stock. Read SEC document |
| May 18, 2018 Filed May 22, 2018 22:21 UTC | WEYERHAEUSER CO WY · Entity 3314 | GrantShare Equilvalents · Derivative | 7,150 | $36.36 Strike: $0.00 | $259,938.25 |
DisclosureSEC source: 0001225208-18-009752 · doc4.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,505.03 Underlying: Common · 7,150 shares Expires not disclosed F1 · derivative.exercise_price: The reported share equivalents were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer into an equal number of share equivalents 3,850 restricted stock units, representing the equity portion of the annual retainer fee in the amount of $140,000, with the number of units determined by dividing the dollar amount of the fees by $36.355 (average of the high ($36.48) and low ($36.23) price of the Issuer's common stock on the fee payment date). The Reporting Person also elected to defer cash fees of $120,000 by conversion into a number of share equivalents determined by dividing the dollar amount of the fees by $36.355. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.exercise_date: The reported share equivalents were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer into an equal number of share equivalents 3,850 restricted stock units, representing the equity portion of the annual retainer fee in the amount of $140,000, with the number of units determined by dividing the dollar amount of the fees by $36.355 (average of the high ($36.48) and low ($36.23) price of the Issuer's common stock on the fee payment date). The Reporting Person also elected to defer cash fees of $120,000 by conversion into a number of share equivalents determined by dividing the dollar amount of the fees by $36.355. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F1 · derivative.expiration_date: The reported share equivalents were acquired pursuant to the Issuer's Fee Deferral Plan for Directors. The Reporting Person elected to defer into an equal number of share equivalents 3,850 restricted stock units, representing the equity portion of the annual retainer fee in the amount of $140,000, with the number of units determined by dividing the dollar amount of the fees by $36.355 (average of the high ($36.48) and low ($36.23) price of the Issuer's common stock on the fee payment date). The Reporting Person also elected to defer cash fees of $120,000 by conversion into a number of share equivalents determined by dividing the dollar amount of the fees by $36.355. Additional share equivalents accrue as and when dividends are paid on the Issuer's common stock. Share equivalents are paid in an equal number of shares of the Issuer's common stock upon the Reporting Person's termination of service as a director. F2 · balance_after: Reported holdings include shares acquired since the Reporting Person's last filing on Form 4 from dividend reinvestment transactions exempt from Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 16:29 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.00 Strike: $115.45 | $0.00 |
DisclosureSEC source: 0001140361-18-019765 · doc1.xml · derivative · entry 1 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2028-04-24 F1 · security: Stock option granted pursuant to the 2012 Equity and Performance-Based Incentive Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. Read SEC document |
| September 13, 2017 Filed Sep 14, 2017 16:57 UTC | PS BUSINESS PARKS, INC./MD PSB · Entity 125076 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $66.00 | $0.00 |
DisclosureSEC source: 0001140361-17-035534 · doc1.xml · derivative · entry 10 Lewis Sara Grootwassink · CIK 0001165970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,068 Underlying: Common Stock · 1,000 shares Expires 2022-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · security: Stock Option granted pursuant to the 2012 Equity and Performance-Based Compensation Plan. Option vests in five (5) equal annual installments beginning one (1) year from the date of grant. F10 · derivative.exercise_price: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014. F10 · shares: This option was previously reported as an option for 2,000 shares of common stock at an exercise price of $68.25, but was adjusted to reflect the special dividend declared by PSB on December 15, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.